Nashville, TX59 Active Studies

Erectile Dysfunction Clinical Trials in Nashville, TX

Find 59 actively recruiting erectile dysfunction clinical trials in Nashville, TX. Connect with local research sites and explore new treatment options.

59
Active Trials
52
Sponsors
12,576
Enrolling

Recruiting Erectile Dysfunction Studies in Nashville

About Erectile Dysfunction Clinical Trials in Nashville

Erectile dysfunction is the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. It affects about 30 million men in the U.S. and is often a sign of underlying cardiovascular disease. Treatment includes PDE5 inhibitors, vacuum devices, and penile implants.

There are currently 59 erectile dysfunction clinical trials recruiting participants in Nashville, TX. These studies are seeking a combined 12,576 participants. Research is being sponsored by University of Utah, Massachusetts General Hospital, Genentech, Inc. and 49 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Erectile Dysfunction Clinical Trials in Nashville — FAQ

Are there erectile dysfunction clinical trials in Nashville?

Yes, there are 59 erectile dysfunction clinical trials currently recruiting in Nashville, TX. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Nashville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Nashville research site will contact you about next steps.

Are clinical trials in Nashville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Nashville studies also compensate for your time and travel.

What erectile dysfunction treatments are being tested?

The 59 active trials in Nashville are testing new therapies including novel drugs, biologics, and treatment approaches for erectile dysfunction.

Data updated July 13, 2026 from ClinicalTrials.gov